Con-Way, Inc. CNW reported 3Q10 EPS from continuing operations of $0.22, “beating our estimate of $0.21 and below consensus of $0.26,” Dahlman Rose & Co. reports.
“Despite the earnings miss to consensus, we believe investors' focus on improved pricing provided a boost to shares. We continue to recommend CNW shares, but only for long term investors,” Dahlman Rose & Co. writes. “We are maintaining our 2010 and 2011 EPS estimates of $0.70 and $2.45, respectively.”
Dahlman Rose & Co. said that its $36 price target remains unchanged.
Con-Way currently trades at $34.87.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in